AN ACT to amend Tennessee Code Annotated, Title 4; Title 29; Title 36; Title 63 and Title 68, relative to assisted reproductive technology.
SB 793 is a narrow reporting bill concerning assisted reproductive technology (ART) in Tennessee. Rather than directly changing licensing rules, medical standards, insurance coverage, parentage law, or other substantive provisions, the bill directs the Commissioner of Health to prepare a report by July 1, 2025, for the chairs of the relevant Senate and House health committees. The report must address the standards and policies governing ART in the state.
Because the bill is framed as a study-and-report measure, it functions as an information-gathering step for lawmakers. It signals legislative interest in reviewing how Tennessee currently regulates fertility and reproductive technology services, but it does not itself amend the referenced titles in a way that creates new duties or rights in the text provided.
The bill’s immediate legal effect is limited: it imposes a reporting obligation on the Commissioner of Health and does not, on its face, alter existing Tennessee statutes governing health care, family law, professional regulation, or reproductive services. Any broader impact would depend on future legislation informed by the report, potentially affecting assisted reproduction providers, patients seeking fertility treatment, and related legal issues such as standards of care, policy oversight, and regulatory consistency across Titles 4, 29, 36, 63, and 68.
With no committee transcript or recorded votes available, the bill’s sentiment can only be inferred from its structure and sponsorship. The measure appears generally neutral and administrative in tone, suggesting a bipartisan or at least low-conflict interest in collecting information before making policy changes. Its focus on a report rather than immediate regulation may indicate an effort to build a factual record on a sensitive health policy topic.
No specific points of contention are documented in the available materials, since there are no transcripts or vote records. Potential areas of future debate, however, could include whether Tennessee should regulate assisted reproductive technology more strictly, how ART intersects with family law and parentage, whether patient access or provider standards should be expanded or limited, and whether the state should address ethical, medical, or insurance-related questions through legislation after the report is delivered.